Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance for the Detection of Calcified Coronary Arteries
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Summary
This study is a single-center, prospective, controlled, diagnostic study. The study will be consecutive and is expected to enroll 100 patients with CCTA confirmed coronary calcified lesions. The purpose of this study was to compare the accuracy of novel Ferumoxytol-enhanced Cardiac Magnetic Resonance (Fe-CMR) and coronary CT angiography (CCTA) in detecting calcified coronary arteries, using coronary angiography (CAG) and optical coherence imaging (OCT) as gold standards.
Official title: Diagnostic Performance of a Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance for the Detection of Calcified Coronary Arteries: A Single-center Clinical Study.
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2024-01-26
Completion Date
2027-08-31
Last Updated
2026-02-10
Healthy Volunteers
No
Conditions
Interventions
Superparamagnetic Iron Oxide Nanoparticles
Patients will receive a novel ferumoxytol-enhanced cardiac magnetic resonance imaging.
Locations (1)
First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China